Evommune (EVMN) Leases (2024 - 2025)
Evommune (EVMN) has disclosed Leases for 2 consecutive years, with $1.5 million as the latest value for Q4 2025.
- Quarterly Leases rose 211.23% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 211.23% year-over-year, with the annual reading at $1.5 million for FY2025, 211.23% up from the prior year.
- Leases for Q4 2025 was $1.5 million at Evommune, up from $160000.0 in the prior quarter.
- The five-year high for Leases was $1.5 million in Q4 2025, with the low at $160000.0 in Q3 2025.